The Past, Present and Future of Asbestos-Related Diseases in Australia: What Are the Data Telling Us?

Author:

Mahoney Kathleen1,Driscoll Tim2ORCID,Collins Julia1,Ross Justine1

Affiliation:

1. Asbestos Safety and Eradication Agency, Surry Hills, NSW 2010, Australia

2. Sydney School of Public Health, University of Sydney, Sydney, NSW 2006, Australia

Abstract

Exposure to asbestos fibres causes asbestosis, mesothelioma and several other cancers, which together are commonly referred to as asbestos-related diseases (ARDs). The use of asbestos increased rapidly in Australia and overseas throughout the 1900s, but knowledge about the health effects of exposure and subsequent controls came about more gradually. In Australia today, an estimated 4000 people still die annually from ARDs. While most of these deaths are due to past occupational exposures, there is ongoing concern about the many potential sources of asbestos exposure remaining in homes and the broader built environment as a legacy of past use. Current evidence indicates that Australians will continue to be exposed to legacy asbestos occupationally and non-occupationally, and continue to develop ARDs, without targeted action to prevent it. Evidence of ongoing exposure highlights the importance of better understanding how and why such exposures might still occur, and how they can be effectively prevented or controlled, with the aim of preventing the disease in the future. A better characterisation of this risk is also necessary to enable effective risk management and appropriate risk communication that is relevant to the current Australian context. This article explores the past, present and future of ARDs in Australia, considers the risk of a new wave of ARDs from legacy asbestos, and identifies where further study is required so that sustainable policies and practices can be developed to prevent a future wave of diseases.

Publisher

MDPI AG

Subject

Management, Monitoring, Policy and Law,Renewable Energy, Sustainability and the Environment,Geography, Planning and Development,Building and Construction

Reference85 articles.

1. International Agency for Research on Cancer (IARC) (2023, February 28). Arsenic, Metals, Fibres and Dusts. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100C: Asbestos (Chrysotile, Amosite, Crocidolite, Tremolite, Actinolite and Anthophyllite). Available online: http://publications.iarc.fr/120.

2. GBD 2016 Occupational Carcinogens Collaborators (2020). Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: A systematic analysis for the Global Burden of Disease Study 2016. Occup. Environ. Med., 77, 151–159.

3. Global Burden of Disease Collaborative Network (2023, February 28). Global Burden of Disease Study 2019 (GBD 2019) Results. Institute for Health Metrics and Evaluation (IHME): Seattle, WA, USA. Available online: https://vizhub.healthdata.org/gbd-results/.

4. The Ecological Association between Asbestos Consumption and Asbestos-Related Diseases 15 Years Later;Rath;Environ. Health Perspect.,2022

5. Brown, B., Hollins, I., Pickin, J., and Donovan, S. (2023). Asbestos Stocks and Flows Legacy in Australia. Sustainability, 15.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3